UCHL1 and neuroblastoma: In cancer-related studies, LDN-57444 was used to identify a role for UCHL1 as a prognostic marker in neuroblastoma cell differentiation, and there have even been attempts to formulate this compound to improve its aqueous solubility in order to treat invasive carcinomas [87].